Nana Shimoyachi
Papers
1
Total Citations
6
H-Index
1
About
Nana Shimoyachi is a rising researcher in radiation oncology, with a focused expertise in ultrahypofractionated radiotherapy for prostate cancer. Her major contribution lies in comparative treatment planning, where she systematically evaluates the dosimetric and clinical trade-offs between high-dose-rate brachytherapy (HDR-BT) and stereotactic body radiotherapy (SBRT)—including both robotic and conventional platforms. Her 2023 study, which has already garnered 6 citations, provides critical insights into how these advanced techniques differ in dose distribution, organ-at-risk sparing, and treatment delivery precision. This work directly informs clinical decision-making for ultrahypofractionation, a rapidly growing paradigm in prostate cancer care. By quantifying the relative strengths of each modality, Shimoyachi helps bridge the gap between technological innovation and practical patient outcomes. Her research is particularly valuable for radiation oncologists and medical physicists seeking evidence-based guidance on treatment selection. As ultrahypofractionation continues to gain traction, Shimoyachi’s comparative analyses are becoming essential references for optimizing prostate cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1